Application 213392
- Type
- ANDA
- Sponsor
- GRANULES PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | SOLUTION;ORAL | 20MEQ/15ML | No | No |
| 002 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | SOLUTION;ORAL | 40MEQ/15ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70010-072 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70010-072 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70010-073 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70010-073 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc. | ANDA | Current |